Health In Tech director plans sale of 17,730 shares

Health In Tech, Inc. (HIT) director Timothy Hayes filed a Rule 144 notice indicating an intention to sell shares of the company’s common stock.

Rhea-AI Filing Summary

Health In Tech, Inc. (HIT) director Timothy Hayes filed a Rule 144 notice indicating an intention to sell shares of the company’s common stock. Hayes reports beneficial ownership of 17,730 shares, with an aggregate market value of $16,363.40, held at Apex Clearing.

The notice lists planned sales tied to restricted stock award vesting events: 12,000 shares vesting on October 3, 2025 and 5,730 shares vesting on January 8, 2026, with both blocks indicated for potential sale on October 8, 2025.

Key Figures

Shares beneficially owned: 17,730 shares Aggregate market value: $16,363.40 Shares from October 3, 2025 vesting: 12,000 shares +2 more

5 metrics

Shares beneficially owned 17,730 shares Common stock held for the account of Timothy Hayes

Aggregate market value $16,363.40 Value associated with the 17,730 shares of common stock

Shares from October 3, 2025 vesting 12,000 shares Restricted Stock Award Vesting, indicated for potential sale

Shares from January 8, 2026 vesting 5,730 shares Restricted Stock Award Vesting, indicated for potential sale

Planned sale date October 8, 2025 Date listed for potential sale of both share blocks

Key Terms

Rule 144, Restricted Stock Award Vesting, aggregate market value, Nasdaq Stock Market

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Award Vesting financial

"Common | 10/03/2025 | Restricted Stock Award Vesting | Health In Tech, Inc."

aggregate market value financial

"Common | APEX CLEARING ... | 17730 | 16363.40 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Nasdaq Stock Market market

"53834658 | 09/10/2026 | Nasdaq Stock Market"

The Nasdaq Stock Market is a place where many companies' shares are bought and sold, functioning like a marketplace for investing in businesses. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping people grow their wealth or fund business growth. Known for hosting many technology and innovative companies, it is a key indicator of the health of those sectors.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Health In Tech, Inc. (HIT)?

It discloses that director Timothy Hayes filed a Rule 144 notice to potentially sell 17,730 shares of Health In Tech, Inc. common stock, tied to restricted stock award vesting events and held at Apex Clearing.

How many Health In Tech (HIT) shares does Timothy Hayes report owning in this Form 144?

Timothy Hayes reports beneficial ownership of 17,730 shares of Health In Tech, Inc. common stock, with an aggregate market value of $16,363.40 as shown in the securities information section.

How many HIT shares are indicated for sale under this Rule 144 notice?

The notice lists a total of 17,730 shares of Health In Tech, Inc. common stock indicated for potential sale, including 12,000 shares from an October 3, 2025 vesting and 5,730 shares from a January 8, 2026 vesting.

What are the vesting dates of the restricted stock awards in the HIT Form 144?

The restricted stock awards are stated to vest on October 3, 2025 for 12,000 shares and on January 8, 2026 for 5,730 shares of Health In Tech, Inc. common stock.

When are the Health In Tech (HIT) shares planned to be sold under this filing?

Both blocks of shares—12,000 and 5,730—are listed with a planned sale date of October 8, 2025 in the securities-to-be-sold section of the Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 11:19 AM Accepted by SEC EDGAR 09/14/2026 - 11:19 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002020283
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Health In Tech, Inc.
SEC File Number	001-42449
Address of Issuer	701 S. Colorado Ave Suite 1. Stuart FLORIDA 34994
Phone	8883730333
Name of Person for Whose Account the Securities are To Be Sold	Hayes Timothy
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	DIRECTOR

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	APEX CLEARING 350 N ST. PAUL ST SUITE 300 DALLAS TX 75201	17730	16363.40	53834658	09/10/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/03/2025	Restricted Stock Award Vesting	Health In Tech, Inc.			12000	10/08/2025	N/A
Common	01/08/2026	Restricted Stock Award Vesting	Health In Tech, Inc.			5730	10/08/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Timothy Hayes
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)